Skip to main content
CriticalFDAfda-F-0617-2024SALMONELLA CONTAMINATION

Whole cantaloupe 3ct and 6ct

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
193
Recall Date
November 17, 2023
Issuing Agency
Hazard
Salmonella Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0617-2024.

TruFresh in Nogales, AZ issued a voluntary recall of its Malichita, Mexico-sourced whole cantaloupe sold in the United States for potential Salmonella contamination.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0617-2024.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Freshpoint Dallas or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0617-2024.

FreshPoint Dallas

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Freshpoint Dallas Recall FAQ

Freshpoint Dallas is the subject of a food safety report: Whole cantaloupe 3ct and 6ct. The notice was published on November 17, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 193 units are potentially affected.